DELAFIELD, Wis. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high, or takes out a prior overhead resistance point, then it's free to find new buyers and momentum players that can ultimately push the stock significantly higher.
One example of a successful breakout trade I flagged recently was development-stage biopharmaceutical player Biodel (BIOD), which I featured in July 18's "5 Stocks Under $10 Set to Soar" at around $4.60 a share. I mentioned in that piece that shares of BIOD had been trending sideways, with the stock moving between $3.93 on the downside and $5.11 on the upside. The stock was just starting to break out above some near-term overhead resistance at $4.46 a share, and it was quickly moving within range of triggering a major breakout trade above the upper-end of its recent range at $4.46 to $5.11 a share.
Guess what happened? Shares of BIOD didn't wait long to trigger that move, since the stock started to break out on July 29 with heavy upside volume. After shares of BIOD cleared resistance at $4.46 to $5.11 a share with strong volume, then the stock quickly tagged its recent 52.week high at $6.08 a share. That represents a gain of just over 30% for anyone who loaded up on BIOD once it triggered that technical breakout. You can see here how powerful trading breakouts can be, and the key is always to follow price and volume.
Hot Up And Coming Stocks To Buy Right Now: Newcastle Investment Corp (NCT)
Newcastle Investment Corp. (Newcastle) is a real estate investment and finance company. Newcastle invests in, and actively manages, a portfolio of, real estate securities, loans, excess mortgage servicing rights (MSRs) and other real estate related assets. The Company segments include unlevered CDOs, which include unlevered investments in deconsolidated Newcastle CDO debt; unlevered excess MSRs; non-recourse other, which includes investments financed with other non-recourse debt; recourse, which includes investments and debt repurchases financed with recourse debt; unlevered other, which includes other unlevered investments, and corporate. In April 2011, Newcastle sold its retained interests in Newcastle CDO VII, a non-consolidated VIE of Newcastle. On May 15, 2013, the Company announced the spin-off of New Residential Investment Corp. In June 2013, Newcastle Investment Corp completed the sale of 100% of the assets in Newcastle CDO IV.
Real Estate Securities
Newcastle underwrite, acquire and manage a portfolio of credit sensitive real estate securities, including commercial mortgage backed securities (CMBS), senior unsecured real estate investment trust (REIT) debt issued by REITs, real estate related asset backed securities (ABS), including subprime securities, and Federal National Mortgage Association (FNMA)/ Federal Home Loan Mortgage Corp. (FHLMC) securities. As of December 31, 2011, the Company�� real estate securities represented 47.4% of its assets.
Real Estate Related Loans
Newcastle acquires and originates loans to real estate owners, including B-notes, mezzanine loans, corporate bank loans, and whole loans. As of December 31, 2011, the Company�� real estate related loans represented 22.3% of its assets.
Residential Mortgage Loans
Newcastle acquires residential mortgage loans, including manufactured housing loans and subprime mortgage loans. As of December 31, 2011, the Company�� residential mortgage loans rep! resented 9.1% of its assets.
Operating Real Estate
Newcastle acquires and manages direct and indirect interests in operating real estate. As of December 31, 2011, the Company�� operating real estate represented 0.9% of its assets.
Excess Mortgage Servicing Rights
Newcastle invested in excess MSRs in December 2011. As of December 31, 2011, the Company�� interests in these rights represented 1.2% of its assets.
Advisors' Opinion:- [By Matt Koppenheffer and David Hanson]
After an incredible run-up this year, the broader market trend was downward this week, to the tune of 1.6%, but some of the stocks out there were hit particularly hard. In this video, Motley Fool financial analysts Matt Koppenheffer and David Hanson take a look at what was behind three big dives this week:�National Bank of Greece� (NYSE: NBG ) ,�Newcastle Investment� (NYSE: NCT ) , and�American Capital Mortgage Investment� (NASDAQ: MTGE ) .�
- [By Albert Alfonso]
On April 26, Newcastle Investment Corp. (NCT) finally announced the spin-off date for shares in its wholly owned subsidiary New Residential (NRZ). The distribution is expected to be made on or about May 15, 2013. Below is a helpful timeline from the presentation related to the spin-off of New Residential:
- [By Amanda Alix]
This turn of events worked in favor of Fortress Investment Group's (NYSE: FIG ) portfolio, which held the former Centex Corp, the subprime mortgage lending unit of a Texas homebuilder. That company is now Nationstar, which is definitely doing its fair share to add to its parent's bottom line. Also owned by Fortress is Newcastle Investment (NYSE: NCT ) , the diversified REIT with an involvement in almost anything to do with real estate, whether residential or commercial.
- [By Eric Volkman]
Newcastle Investment (NYSE: NCT ) shareholders will find a little less money in their pockets following a reduction in the company's common stock dividend. A fresh quarterly payout of $0.17 per share will be handed out on July 31 to shareholders of record as of June 13. That amount is a nickel lower than the firm's previous distribution of $0.22 per share. The upcoming payout, however, will be the first one since Newcastle completed the divestment of onetime subsidiary New Residential Investment.
5 Best Prefered Stocks To Watch Right Now: WidePoint Corp (WYY)
WidePoint Corporation (WidePoint), incorporated on May 30, 1997, is a provider of customized technology-based products and solutions to both the government sector and commercial markets. The Company operates in three segments: Communications Management, Cybersecurity Solutions, and Consulting Services and Products. WidePoint, through its wholly owned subsidiaries iSYS LLC (iSYS) and WidePoint Solutions Corp. (WSC), utilizes its experience working with government and commercial enterprises to develop solutions that take the pain out of managing wireless and wireline telecommunications (telecom) expenses and devices. Through its wholly owned subsidiaries Operational Research Consultants (ORC), Protexx Technology Corporation (PROTEXX), and Advanced Response Concepts Corporation (ARCC), delivers compliant identity management solutions. The Company offers a range of information technology (IT) consulting services and products to support its clients��IT needs.
Communications Management
The Company offers a Bands of Minutes approach that takes advantage of bulk savings for its clients by utilizing all available voice, data and message plans offered by the carriers. It provides a variety of reports that provide data for ongoing periodic reviews and strategic decision-making. It also provides secured solutions for its clients��telecom assets.
Cybersecurity Solutions
WidePoint�� wholly owned subsidiary, ORC, is certified by the federal government to facilitate public access to the services offered by government agencies, including on-line access to computers for purposes of reviewing, retrieving, providing, and exchanging information. Its digital certificate credentials are authorized to provide trusted individual or business identity information for use by the Department of Defense (DoD), FirstGov, General Services Administration (GSA) and participating federal government agencies. Its digital certificate credential services include the DoD External Cer! tificate Authority, Access Certificates for Electronic Services, and the General Services Administration Shared Service Provider. It also provide an analysis of an organization�� business and technical policies across application and data resources for the implementation of various devices, such as smart cards, security tokens, cell phones and personal computers, and implementing these capabilities by incorporating higher levels of automated infrastructure.
Consulting Services and Products
The Company offers IT architecture and planning services to ensure that it clients get the most from their IT investments. Its system integration services team provides its clients with the creative and technical expertise needed to execute projects of any size. The Company specializes in the areas of Infrastructure management, Applications management and IT strategic planning. iSYS provides a range of IA support services to help its customers to protect and defend information and information systems by ensuring confidentiality, integrity, authentication, availability, and non-repudiation. In addition, its IA services include strategic risk analysis and management support that includes physical security, reliability, continuity of operations planning, and support for other enterprise governance issues, such as privacy, compliance, audits and disaster recovery. Its IA services include Certification and Accreditation; Security Architecture Design; System Security Planning; Security Risk Assessment and Mitigation Planning; Vulnerability Testing and Remediation; Customizable IA plans and processes to correspond to customer needs, and Continuity of Operations Planning. Its support services address on-going enhancements to existing IT systems along with developing new IT systems that incorporate the evolution of long-term advanced hardware and software technologies.
The Company competes with Avalon Global Solutions, Inc., Profitline, Rivermine, Lockheed Martin Corporation, Northrop G! rumman Co! rporation, EDS, Unisys, Computer Services Corporation, Science Applications International Corporation and Manpower.
Advisors' Opinion:- [By Bryan Murphy]
If you're a fan of, or investor in, WidePoint Corporation (NYSEMKT:WYY), then be warned now that what you're about to read regarding WYY is likely to irritate you. Nothing personal; it's just a reality check. Here goes - WidePoint shares are very likely to be at the onset of a sizeable pullback. [Insert boos and hisses here.]
5 Best Prefered Stocks To Watch Right Now: Siebert Financial Corp.(SIEB)
Siebert Financial Corp., through its subsidiary, Muriel Siebert & Co., Inc., engages in the retail discount brokerage and investment banking operations in the United States. The company provides Internet and traditional discount brokerage and related services to retail investors; independent retail execution services; and retail customer services. It also offers various self-directed retirement accounts, for which it acts as agent on various transactions; and lends customers a portion of the market value of certain securities held in the customer?s account through its clearing agent. In addition, the company, through its other subsidiary, Siebert Woman?s Financial Network, Inc., provides products, services, and information to serve women?s financial needs. Further, Siebert Financial Corp. offers equity execution services on an agency basis, as well as equity and fixed income underwriting and investment banking services to institutional investors, and issuers of equity a nd fixed-income securities. The company provides its discount brokerage services through a broker on the telephone, through a wireless device, or via the Internet. It maintains seven retail discount brokerage offices in New York; Jersey City, New Jersey; Boca Raton, Surfside, West Palm Beach, and Naples, Florida; and Beverly Hills, California. The company was founded in 1886 and is headquartered in New York, New York.
Advisors' Opinion:- [By Jon C. Ogg]
Muriel Siebert, founder of Siebert Financial Corp. (NASDAQ: SIEB), passed away over the weekend. Many new investors may not know her nor may they know just how important and influential she was on Wall Street and in the financial services industries. Ms. Siebert died at the age of 80 years old, and we wanted to list some of her accomplishments that have led to at least more equality among women in what had been a men-only club before she came on the stage.
5 Best Prefered Stocks To Watch Right Now: Abbott Laboratories(ABT)
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company offers adult and pediatric pharmaceuticals for rheumatoid and psoriatic arthritis, ankylosing spondylitis, psoriasis, and Crohn's disease; dyslipidemia; HIV infection; prostate cancer, endometriosis and central precocious puberty, and anemia caused by uterine fibroids; respiratory syncytial virus; adult males who have low or no testosterone; secondary hyperparathyroidism; hypothyroidism; and pancreatic exocrine insufficiency, as well as anesthesia products. It also provides diagnostic products, such as immunoassay systems; chemistry systems; assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological, and infectious diseases; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infections agents; genomic-b ased tests; hematology systems and reagents; and point-of-care diagnostic systems and tests for blood analysis. In addition, the company offers a line of pediatric and adult nutritional products. Further, it provides coronary, endovascular, vessel closure, and structural heart devices, such as drug-eluting stent systems, coronary metallic stents, balloon dilatation products, coronary guidewires, vessel closure devices, carotid stent systems, percutaneous valve repair systems, and drug eluting bioresorbable vascular products. Additionally, the company provides blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, lasik surgery, contact lens, and dry eye products, as well as branded generic pharmaceutical products. Abbott primarily serves retailers, wholesalers, hospitals, and health care facilities. Abbott was founded in 1888 and is headquartered in Abbott Park, Illinois.
Advisors' Opinion:- [By Keith Speights]
1. Medical device companies
Several medical device companies have already slashed jobs or are planning to do so because of Obamacare. Abbott Labs (NYSE: ABT ) began shedding the first of 1,900 jobs a few years ago. The company attributed the cuts partially to new fees and pricing pressures resulting from the Affordable Care Act. - [By Sean Williams]
For this I believe we're going to see the Centers for Disease Control and Prevention turn up its attempts to increase hepatitis-C testing awareness which may turn out great for medical device maker Abbott Laboratories (NYSE: ABT ) . In June, Abbott received approval from the FDA for its hepatitis-C genotype testing device, which will better help doctors determine how to treat infected patients thanks to precise genotype mapping.�
- [By Dan Carroll]
Abbott Labs'� (NYSE: ABT ) stock has surged this year, shooting up more than 15% since the start of 2013. Despite the company's spinoff of former pharmaceutical firm AbbVie (NYSE: ABBV ) �-- a move that waved goodbye to its high-growth pharmaceuticals business, including massive immunology blockbuster Humira that pulled in $9 billion in sales last year -- Abbott has still managed to find growth by turning to a new engine: emerging markets.
- [By Rich Smith]
Don't look now, but Abbott Labs (NYSE: ABT ) is about to buy itself a bit of growth.
On Monday, the Abbott Park, Ill.-based medical products giant announced that it has agreed to buy privately held medical device-maker IDEV Technologies for $310 million, net of cash and debt. In return, it will gain IDEV's portfolio of products that include, importantly, the SUPERA Veritas self-expanding nitinol stent system, used for opening blocked blood vessels. Approved for use in Europe, SUPERA Veritas has only limited approval for use in the U.S. but is in the process of seeking FDA approval for expanded usage.
No comments:
Post a Comment